UVA has risen from 21st to 19th in National Institutes of Health support among all public medical schools.
Researchers at UVA Cancer Center have found that they can identify acute myeloid leukemia patients at risk of poor outcomes by measuring specific "bioactive molecules" in their cancer cells.
Promising research suggests we can used sound waves to treat debilitating cavernomas that can cause seizures, paralysis and even death.
For the sixth year in a row, work emerging from UVA Health and the School of Medicine has been recognized as UVA's biggest innovation.
A new discovery by our Swapnil K. Sonkusare, PhD, and his team could improve the success of lung transplants and help recipients live longer, healthier lives.
Our George Bloom, PhD, has found some of the first evidence of how toxic tau proteins harm neurons in the brain, which could lead to new treatments for Alzheimer's disease.